Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumors

Author: de Jonge M.J.A.   Droz J.P.   Paz-Ares L.   van Oosterom A.T.   de Wit R.   Chollet P.   Baron B.   Lacombe D.   Mettinger K.   Fumoleau P.  

Publisher: Springer Publishing Company

ISSN: 0167-6997

Source: Investigational New Drugs, Vol.22, Iss.3, 2004-08, pp. : 329-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content